Literature DB >> 18992081

Expression and hormonal regulation of IL-11Ralpha in canine uterus during early pregnancy.

B Guo1, B-C Han, Z Tian, T-Y Zhao, L Zeng, Z-M Yang, Z-P Yue.   

Abstract

Embryo implantation is critical for the successful establishment of pregnancy. Interleukin-11 (IL-11) is essential for adequate decidualization in the mouse and human via binding to the specific IL-11 receptor alpha (IL-11Ralpha). But the expression and regulation of IL-11 and IL-11Ralpha in the canine endometrium remain unknown. The aim of this study was to investigate the differential expression of IL-11Ralpha in canine uterus during early pregnancy and its regulation under different conditions by in situ hybridization. Interleukin-11Ralpha mRNA was mainly localized in glandular epithelium in canine uterus. There was a low level of IL-11Ralpha expression in the glandular epithelium on days 6, 12 and 17 of pregnancy. On day 20 of pregnancy when embryo implanted, IL-11Ralpha mRNA was highly expressed in the glandular epithelium surrounding the embryo, but not in the luminal epithelium and stroma. On day 23 of pregnancy, the expression of IL-11Ralpha mRNA maintained a constant level compared with the expression of day 20 and increased on day 28 of pregnancy. During the oestrous cycle, a high level of IL-11Ralpha mRNA expression was seen in the oestrous uterus. Progesterone slightly induced the expression of IL-11Ralpha mRNA in the ovariectomized canine uterus. These results suggest that IL-11Ralpha expression is closely related to canine implantation and up-regulated by progesterone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18992081     DOI: 10.1111/j.1439-0531.2008.01072.x

Source DB:  PubMed          Journal:  Reprod Domest Anim        ISSN: 0936-6768            Impact factor:   2.005


  1 in total

Review 1.  Progesterone and Inflammatory Response in the Oviduct during Physiological and Pathological Conditions.

Authors:  Emily A McGlade; Akio Miyamoto; Wipawee Winuthayanon
Journal:  Cells       Date:  2022-03-23       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.